Suppr超能文献

胶囊内镜在小肠出血中的应用:最新进展。

Capsule endoscopy for small bowel bleed: Current update.

机构信息

Institute of Gastrosciences and Liver Transplantation, Apollo Multispeciality Hospitals, Kolkata, 700 054, India.

出版信息

Indian J Gastroenterol. 2024 Oct;43(5):896-904. doi: 10.1007/s12664-024-01637-8. Epub 2024 Aug 2.

Abstract

Small intestine, hitherto an obscure area for endoscopists before 2000, is now easily evaluated non-invasively using capsule endoscopy and invasively by device-assisted enteroscopies. Major advances in understanding the causes and management of small bowel diseases have been in obscure gastrointestinal (GI) bleed, currently re-named as small bowel bleed, after the discovery of capsule endoscopy. The current article is a narrative review of the technology of capsule endoscopy, its advantages and limitations, future perspective and Indian studies on its utility in patients with small bowel bleed. Till date, eight large series reporting 2319 patients with obscure GI bleed (1554 overt and 765 occult) undergoing capsule endoscopy have been reported from India. Overall yield of capsule endoscopy to detect lesions in these studies varied from 43.5% to 90%. The major causes detected in various studies for small bowel bleed include vascular malformation, portal hypertensive enteropathy, ulcer, stricture, tumor, polyps, etc. Hookworm can cause both occult as well as overt small bowel bleed as shown mainly from India. Capsule endoscopy has also been quite safe in patients with small bowel bleed as despite 0.6% to 15% retention of imaging capsule in Indian studies, development of clinically evident small bowel obstruction has rarely been reported. The major limitations of capsule endoscopy include lack of maneuvrability and therapeutic capability. Research is in progress to overcome some of the limitations of the current capsule endoscopy system. It is concluded that discovery of capsule endoscopy has brought a new paradigm in GI endoscopy and explored a hitherto unexplored area of GI tract, i.e. small bowel that continued to be a black box for the endoscopists.

摘要

小肠在 2000 年以前一直是内镜医生的盲区,现在通过胶囊内镜可以非侵入性地进行评估,通过器械辅助的小肠镜也可以进行侵入性检查。在理解小肠疾病的病因和治疗方面的主要进展是在不明原因的胃肠道(GI)出血,在发现胶囊内镜后,现在更名为小肠出血。本文是对胶囊内镜技术的叙述性综述,包括其优点和局限性、未来展望以及印度在胶囊内镜对小肠出血患者的实用性方面的研究。迄今为止,印度已经报道了 8 项大型系列研究,涉及 2319 例不明原因的 GI 出血(1554 例显性和 765 例隐性)患者接受了胶囊内镜检查。这些研究中,胶囊内镜检测到病变的总体检出率从 43.5%到 90%不等。在各种研究中,检测到的导致小肠出血的主要原因包括血管畸形、门静脉高压性肠病、溃疡、狭窄、肿瘤、息肉等。钩虫可引起显性和隐性小肠出血,这主要是从印度得到的发现。胶囊内镜在小肠出血患者中也非常安全,尽管印度的研究中有 0.6%到 15%的成像胶囊被滞留,但很少有临床明显的小肠梗阻的报道。胶囊内镜的主要局限性包括缺乏可操作性和治疗能力。目前正在研究如何克服当前胶囊内镜系统的一些局限性。结论是,胶囊内镜的发现带来了 GI 内镜的新范例,并探索了 GI 道一个以前未被探索的区域,即小肠,这一直是内镜医生的盲区。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验